SMi Group Reports: There is now 5 weeks left before the Orphan Drugs and Rare Diseases Conference. We’ve got the list of participants that was released today.

LONDON, UNITED KINGDOM, September 16, 2015 /EINPresswire.com/ -- SMi’s 4th annual Orphan Drugs and Rare Diseases Conference will be taking place in London, UK, on 19th – 20th October 2015.
SMi Group Reports (15.09.15. – London, UK): There is now 5 weeks left before the Conference.
We’ve got the list of participants that was released today. To review, please visit: www.oprhandrugs-event.com

This must attend event will review recent developments in the orphan drug and rare diseases industry and provide attendees with the opportunity to gain in-depth knowledge by: Learning about key strategies and collaborations to accelerate rare disease clinical drug development, enhancing knowledge on the role of patient organisations in promoting drug development for their disease and discover how gene therapy is a very real factor in clinical trials.

Why you should attend?
•Review how big pharma is positioning itself in the emerging orphan drug industry
•Discuss academic and big pharma perspectives on how to overcome the challenges of rare diseases
•Understand how patients and families are key team players in improving therapy development

Key speakers in 2015 include: Rare Disease UK (RDUK), GSK Rare Diseases, GSK, Roche Pharma Research and Early Development, International Regulatory Affairs department- GENETHON, Rare Disease Research Unit –Pfizer, DORPHAN S.A., Abeona Therapeutics, and many more

To register today please visit: www.orphandrugs-event.com
Alternatively, contact Fateja Begum: +44 (0) 20 7827 6184/ fbegum@smi-online.co.uk

In addition to the event, there will be two interactive post-conference workshops:
Market Access to Orphan Drugs: Controversies, Trends and Solutions, led by Colette Hamilton, Managing Director, ATP Market Access.
And The Rare Disease Patient Perspective - From Regulatory to Clinical Execution, led by Christa van Kan, Team Lead Clinical Execution, PSR Orphan Experts.

For more information please visit: www.orphandrugs-event.com

------------------------- END --------------------------
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Anna Serazetdinova
SMi Group Ltd
+44 (0) 20 7827 6184
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.